247 related articles for article (PubMed ID: 3545448)
1. Proteases occurring in the cell membrane: a possible cell receptor for the Bowman-Birk type of protease inhibitors.
Yavelow J; Caggana M; Beck KA
Cancer Res; 1987 Mar; 47(6):1598-601. PubMed ID: 3545448
[TBL] [Abstract][Full Text] [Related]
2. Potential intracellular target proteins of the anticarcinogenic Bowman Birk protease inhibitor identified by affinity chromatography.
Billings PC; St Clair W; Owen AJ; Kennedy AR
Cancer Res; 1988 Apr; 48(7):1798-802. PubMed ID: 3280120
[TBL] [Abstract][Full Text] [Related]
3. Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman-Birk protease inhibitor.
Billings PC; Habres JM; Liao DC; Tuttle SW
Cancer Res; 1991 Oct; 51(20):5539-43. PubMed ID: 1913672
[TBL] [Abstract][Full Text] [Related]
4. Bowman-Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1.
Chen YW; Huang SC; Lin-Shiau SY; Lin JK
Carcinogenesis; 2005 Jul; 26(7):1296-306. PubMed ID: 15746161
[TBL] [Abstract][Full Text] [Related]
5. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
Ware JH; Wan XS; Rubin H; Schechter NM; Kennedy AR
Arch Biochem Biophys; 1997 Aug; 344(1):133-8. PubMed ID: 9244390
[TBL] [Abstract][Full Text] [Related]
6. Effect of the Bowman-Birk inhibitor (a soy protein) on in vitro bladder neck/urethral and penile corporal smooth muscle activity.
Malkowicz SB; Liu SP; Broderick GA; Wein AJ; Kennedy AR; Levin RM
Neurourol Urodyn; 2003; 22(1):54-7. PubMed ID: 12478602
[TBL] [Abstract][Full Text] [Related]
7. Suppression of 3-methylcholanthrene-induced cellular transformation by timed administration of the Bowman-Birk protease inhibitor.
St Clair WH
Carcinogenesis; 1991 May; 12(5):935-7. PubMed ID: 2029760
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of oral carcinogenesis by a protease inhibitor.
Messadi DV; Billings P; Shklar G; Kennedy AR
J Natl Cancer Inst; 1986 Mar; 76(3):447-52. PubMed ID: 3081747
[TBL] [Abstract][Full Text] [Related]
9. Complete amino acid sequence of the lentil trypsin-chymotrypsin inhibitor LCI-1.7 and a discussion of atypical binding sites of Bowman-Birk inhibitors.
Weder JK; Hinkers SC
J Agric Food Chem; 2004 Jun; 52(13):4219-26. PubMed ID: 15212472
[TBL] [Abstract][Full Text] [Related]
10. In vitro inhibition of the activation of Pro-matrix Metalloproteinase 1 (Pro-MMP-1) and Pro-matrix metalloproteinase 9 (Pro-MMP-9) by rice and soybean Bowman-Birk inhibitors.
Bawadi HA; Antunes TM; Shih F; Losso JN
J Agric Food Chem; 2004 Jul; 52(15):4730-6. PubMed ID: 15264907
[TBL] [Abstract][Full Text] [Related]
11. Nanomolar concentrations of Bowman-Birk soybean protease inhibitor suppress x-ray-induced transformation in vitro.
Yavelow J; Collins M; Birk Y; Troll W; Kennedy AR
Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5395-9. PubMed ID: 3860869
[TBL] [Abstract][Full Text] [Related]
12. Bowman-Birk inhibitor suppresses production of superoxide anion radicals in differentiated HL-60 cells.
Ware JH; Wan XS; Kennedy AR
Nutr Cancer; 1999; 33(2):174-7. PubMed ID: 10368813
[TBL] [Abstract][Full Text] [Related]
13. Effects of the Bowman-Birk inhibitor on clonogenic survival and cisplatin- or radiation-induced cytotoxicity in human breast, cervical, and head and neck cancer cells.
Zhang L; Wan XS; Donahue JJ; Ware JH; Kennedy AR
Nutr Cancer; 1999; 33(2):165-73. PubMed ID: 10368812
[TBL] [Abstract][Full Text] [Related]
14. Preparation and production of a cancer chemopreventive agent, Bowman-Birk inhibitor concentrate.
Kennedy AR; Szuhaj BF; Newberne PM; Billings PC
Nutr Cancer; 1993; 19(3):281-302. PubMed ID: 8346077
[TBL] [Abstract][Full Text] [Related]
15. Antiapoptotic activity of the Bowman-Birk inhibitor can be attributed to copurified phospholipids.
Foehr MW; Tomei LD; Goddard JG; Pemberton PA; Bathurst IC
Nutr Cancer; 1999; 34(2):199-205. PubMed ID: 10578488
[TBL] [Abstract][Full Text] [Related]
16. Identification of a soluble enzyme from C3H/10T1/2 cells which is inhibited by the Bowman-Birk proteinase inhibitor.
Fagan JM; Waxman L
Biochem Biophys Res Commun; 1991 Aug; 178(3):856-61. PubMed ID: 1872865
[TBL] [Abstract][Full Text] [Related]
17. Proteinase inhibition using small Bowman-Birk-type structures.
Fernandez JH; Mello MO; Galgaro L; Tanaka AS; Silva-Filho MC; Neshich G
Genet Mol Res; 2007 Oct; 6(4):846-58. PubMed ID: 18058707
[TBL] [Abstract][Full Text] [Related]
18. Proteases, protease inhibitors and radiation carcinogenesis.
Kennedy AR
Int J Radiat Biol; 2023; 99(6):882-890. PubMed ID: 34325613
[TBL] [Abstract][Full Text] [Related]
19. Prevention of carcinogenesis by protease inhibitors.
Kennedy AR
Cancer Res; 1994 Apr; 54(7 Suppl):1999s-2005s. PubMed ID: 8137328
[TBL] [Abstract][Full Text] [Related]
20. The Bowman-Birk inhibitor. Trypsin- and chymotrypsin-inhibitor from soybeans.
Birk Y
Int J Pept Protein Res; 1985 Feb; 25(2):113-31. PubMed ID: 3886572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
